Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) just unveiled an update.
Asymchem Laboratories reported its unaudited financial results for the third quarter of 2025, showing a slight decline in quarterly operating revenue by 0.09% compared to the same period last year, but an overall increase of 11.82% from the beginning of the year. Despite a decrease in quarterly net profit by 13.46%, the company experienced a 12.66% increase in net profit for the year to date, indicating a strong performance in the broader financial context. The report highlights a positive trend in the company’s financial health, which could bolster its market position and reassure stakeholders of its growth trajectory.
The most recent analyst rating on (HK:6821) stock is a Buy with a HK$106.30 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a joint stock company incorporated in China, operating in the pharmaceutical industry. The company focuses on providing contract development and manufacturing services to pharmaceutical and biotechnology companies.
Average Trading Volume: 773,105
Technical Sentiment Signal: Buy
Current Market Cap: HK$39.55B
See more data about 6821 stock on TipRanks’ Stock Analysis page.